What is the catalog number for Eotaxin/CCL11 Rabbit Polyclonal Antibody?

The catalog number for Eotaxin/CCL11 Rabbit Polyclonal Antibody is orb312095.

What sizes are available for Eotaxin/CCL11 Rabbit Polyclonal Antibody?

Eotaxin/CCL11 Rabbit Polyclonal Antibody is available in the following size(s): 100 µg.

Is Eotaxin/CCL11 Rabbit Polyclonal Antibody in stock?

Eotaxin/CCL11 Rabbit Polyclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

Eotaxin/CCL11 Rabbit Polyclonal Antibody

Anti-Eotaxin/CCL11 Antibody. Tested in ELISA, WB applications. This antibody reacts with Human.

Product Specifications

Product Name Alternative

Eotaxin; C-C motif chemokine 11; Eosinophil chemotactic protein; Small-inducible cytokine A11; CCL11; SCYA11

UniProt

P51671

Reactivity

Human, Mouse, Rat

Cross Reactivity

No cross-reactivity with other proteins

Immunogen

E. coli-derived human Eotaxin recombinant protein (Position: G24-P97) . Human Eotaxin shares 61.6% and 63% amino acid (aa) sequence identity with mouse and rat Eotaxin, respectively.

Target

Eotaxin

Clonality

Polyclonal

Conjugation

Unconjugated

Field of Research

Immunology & Inflammation

Purification

Immunogen affinity purified.

Concentration

Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.

Dilution

Western blot, 0.1-0.5μg/ml, Human, Mouse, Rat Immunohistochemistry (Paraffin-embedded Section), 2-5μg/ml, Human ELISA, 0.1-0.5μg/ml

Form

Lyophilized

Molecular Weight

11, 15 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

ELISA, IHC, WB

Host or Source

Rabbit

Preservative

Each vial contains antibody formulated with stabilizing components, 0.9mg NaCl, 0.2mg Na2HPO4, 0.01mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.